These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22991320)

  • 41. [Classification and etiopathogenesis of drug hypersensitivity reactions].
    Ebbli C; Salomone M; Tagliassachi C; Truffelli L
    Minerva Anestesiol; 1982 Sep; 48(9):503-30. PubMed ID: 6755300
    [No Abstract]   [Full Text] [Related]  

  • 42. Post-marketing surveillance of the safety profile of iodixanol in the outpatient CT setting: a prospective, multicenter, observational study of patient risk factors, adverse reactions and preventive measures in 9953 patients.
    Müller FH
    Rofo; 2014 Nov; 186(11):1028-34. PubMed ID: 24729407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication.
    Freed KS; Leder RA; Alexander C; DeLong DM; Kliewer MA
    AJR Am J Roentgenol; 2001 Jun; 176(6):1389-92. PubMed ID: 11373198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults.
    Dillman JR; Ellis JH; Cohan RH; Strouse PJ; Jan SC
    AJR Am J Roentgenol; 2007 Dec; 189(6):1533-8. PubMed ID: 18029897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A practical guide to diagnose lesser-known immediate and delayed contrast media-induced adverse cutaneous reactions.
    Böhm I; Schild HH
    Eur Radiol; 2006 Jul; 16(7):1570-9. PubMed ID: 16770655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delayed adverse reaction to nonionic contrast agents.
    Newman B
    Pediatr Radiol; 2001 Aug; 31(8):597-9. PubMed ID: 11550775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunologic basis for adverse reactions to radiographic contrast media.
    Stejskal V; Nilsson R; Grepe A
    Acta Radiol; 1990 Nov; 31(6):605-12. PubMed ID: 2278787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of reactive drug metabolites in immune-mediated adverse drug reactions.
    Hess DA; Rieder MJ
    Ann Pharmacother; 1997 Nov; 31(11):1378-87. PubMed ID: 9391694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immediate hypersensitivity reaction to gadolinium-based MR contrast media.
    Jung JW; Kang HR; Kim MH; Lee W; Min KU; Han MH; Cho SH
    Radiology; 2012 Aug; 264(2):414-22. PubMed ID: 22550309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute adverse reactions to radiographic iodinated and gadolinium-based contrast media: incidence, risk factors and premedication: from published evidence to a practical approach.
    Tonolini M; Bianco R
    Clin Ter; 2011; 162(6):591-4. PubMed ID: 22262334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The potential utility of iodinated contrast media (ICM) skin testing in patients with ICM hypersensitivity.
    Ahn YH; Koh YI; Kim JH; Ban GY; Lee YK; Hong GN; Jin UR; Choi BJ; Shin YS; Park HS; Ye YM
    J Korean Med Sci; 2015 Mar; 30(3):245-51. PubMed ID: 25729245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trends in hypersensitivity drug reactions: more drugs, more response patterns, more heterogeneity.
    Doña I; Barrionuevo E; Blanca-Lopez N; Torres MJ; Fernandez TD; Mayorga C; Canto G; Blanca M
    J Investig Allergol Clin Immunol; 2014; 24(3):143-53; quiz 1 p following 153. PubMed ID: 25011351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Categorization of adverse drug reactions in electronic health records.
    Foreman C; Smith WB; Caughey GE; Shakib S
    Pharmacol Res Perspect; 2020 Apr; 8(2):e00550. PubMed ID: 32302059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests.
    Berti A; Della-Torre E; Yacoub M; Tombetti E; Canti V; Sabbadini MG; Colombo G
    Eur Ann Allergy Clin Immunol; 2016 Jul; 48(4):137-44. PubMed ID: 27425169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonimmediate Maculopapular Erythema Induced by a Gadolinium-Based Contrast Agent.
    Gauthier A; Mankouri F; Demoly P; Chiriac AM
    J Investig Allergol Clin Immunol; 2022 Jun; 32(3):226-228. PubMed ID: 34489230
    [No Abstract]   [Full Text] [Related]  

  • 56. Allergic-like breakthrough reactions to gadolinium contrast agents after corticosteroid and antihistamine premedication.
    Dillman JR; Ellis JH; Cohan RH; Strouse PJ; Jan SC
    AJR Am J Roentgenol; 2008 Jan; 190(1):187-90. PubMed ID: 18094310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media.
    Yamaguchi K; Katayama H; Takashima T; Kozuka T; Seez P; Matsuura K
    Radiology; 1991 Feb; 178(2):363-7. PubMed ID: 1987594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [General adverse reactions to contrast agents. Classification and general concepts].
    Aguilar García JJ; Parada Blázquez MJ; Vargas Serrano B; Rodríguez Romero R
    Radiologia; 2014 Jun; 56 Suppl 1():3-11. PubMed ID: 25304300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of iodine in hypersensitivity reactions to radio contrast media.
    Scherer K; Harr T; Bach S; Bircher AJ
    Clin Exp Allergy; 2010 Mar; 40(3):468-75. PubMed ID: 20210815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A possible role for cysteinyl-leukotrienes in non-ionic contrast media induced adverse reactions.
    Böhm I; Speck U; Schild H
    Eur J Radiol; 2005 Sep; 55(3):431-6. PubMed ID: 16129253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.